Journey Medical Corp Preferred Stock, Accretion of Redemption Discount
Journey Medical Corp (DERM) reported Preferred Stock, Accretion of Redemption Discount of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-31.
Discontinued › Shareholders' Equity
us-gaap:PreferredStockAccretionOfRedemptionDiscount · last filed 2023-03-31
- Journey Medical Corp preferred stock, accretion of redemption discount for the quarter ending 2021-12-31 was $1.81M.
- Journey Medical Corp preferred stock, accretion of redemption discount for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- Journey Medical Corp preferred stock, accretion of redemption discount for fiscal 2021 was $2.85M.
- Journey Medical Corp preferred stock, accretion of redemption discount for fiscal 2020 was $0.00.
| Period end | Preferred Stock, Accretion of Redemption Discount 3 month | Preferred Stock, Accretion of Redemption Discount 9 month | Preferred Stock, Accretion of Redemption Discount 12 month |
|---|---|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-03-31 | ||
| 2021-12-31 | $1.81M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $2.85M 10-K · filed 2023-03-31 | |
| 2021-09-30 | $1.03M 10-Q · filed 2022-11-10 | ||
| 2020-12-31 | $0.00 10-K · filed 2022-03-28 |